Literature DB >> 16710746

1p/19q chromosome deletions in metastatic oligodendroglioma.

Ryan Merrell1, L Burton Nabors, Arie Perry, Cheryl Ann Palmer.   

Abstract

Extracranial metastasis of primary brain tumors is a rare phenomenon. Of the few cases reported of metastatic oligodendroglioma, only two have evaluated genetic alterations, specifically deletions of chromosomes 1p and 19q. Herein, we report two additional patients with metastatic anaplastic oligodendroglioma to bone, both followed until death. All available pathology specimens were reviewed and genetic analysis was performed in one of the cases. Although the bone metastasis was non-informative, the primary intracranial tumor revealed codeletions of the 1p and 19q chromosomal arms, commonly recognized as the genetically favorable profile of oligodendrogliomas. Both patients died of complications related to their systemic disease and did not have any radiologic evidence of intracranial progression at the time of their last MRI studies. Along with the reported literature, our data suggest that despite their generally favorable behavioral profiles, oligodendroglial tumors with 1p/19q deletions may be more prone to metastasis as they progress. Genetic analysis serves a valuable ancillary role in the diagnostic workup of such cases.

Entities:  

Mesh:

Year:  2006        PMID: 16710746     DOI: 10.1007/s11060-006-9179-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

1.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Authors:  Y Ino; R A Betensky; M C Zlatescu; H Sasaki; D R Macdonald; A O Stemmer-Rachamimov; D A Ramsay; J G Cairncross; D N Louis
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

Review 3.  The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature.

Authors:  B H Liwnicz; L J Rubinstein
Journal:  Hum Pathol       Date:  1979-07       Impact factor: 3.466

4.  Trends in incidence of primary brain tumors in the United States, 1985-1994.

Authors:  P J Jukich; B J McCarthy; T S Surawicz; S Freels; F G Davis
Journal:  Neuro Oncol       Date:  2001-07       Impact factor: 12.300

5.  Metastatic anaplastic oligodendroglioma simulating acute leukemia. A case report.

Authors:  Mona Anand; Rajive Kumar; Paresh Jain; Ritu Gupta; Nandita Ghosal; Atul Sharma; Amit Agarwal; Mehar Chand Sharma
Journal:  Acta Cytol       Date:  2003 May-Jun       Impact factor: 2.319

Review 6.  Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.

Authors:  Herbert H Engelhard; Ana Stelea; Arno Mundt
Journal:  Surg Neurol       Date:  2003-11

7.  Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.

Authors:  Kenneth B Fallon; Cheryl A Palmer; Kevin A Roth; L Burton Nabors; Wenquan Wang; Mark Carpenter; Ruma Banerjee; Peter Forsyth; Keith Rich; Arie Perry
Journal:  J Neuropathol Exp Neurol       Date:  2004-04       Impact factor: 3.685

8.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Authors:  J G Cairncross; K Ueki; M C Zlatescu; D K Lisle; D M Finkelstein; R R Hammond; J S Silver; P C Stark; D R Macdonald; Y Ino; D A Ramsay; D N Louis
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

Review 9.  Metastatic anaplastic oligodendroglioma.

Authors:  D R Macdonald; R A O'Brien; J J Gilbert; J G Cairncross
Journal:  Neurology       Date:  1989-12       Impact factor: 9.910

Review 10.  Bony metastases of anaplastic oligodendroglioma respond to temozolomide.

Authors:  Tara Morrison; Juan M Bilbao; Guisheng Yang; James R Perry
Journal:  Can J Neurol Sci       Date:  2004-02       Impact factor: 2.104

View more
  3 in total

1.  Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.

Authors:  Céline Duval; Marie de Tayrac; Karine Michaud; Florian Cabillic; Claudie Paquet; Peter Vincent Gould; Stéphan Saikali
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

Review 2.  Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.

Authors:  Gang Li; Zhiguo Zhang; Jianghong Zhang; Tianbo Jin; Hongjuan Liang; Li Gong; Guangbin Cui; Haixia Yang; Shiming He; Yongsheng Zhang; Guodong Gao
Journal:  Diagn Pathol       Date:  2014-01-21       Impact factor: 2.644

3.  Osteosclerosis Secondary to Metastatic Oligodendroglioma.

Authors:  Patrick R Maloney; Vitor Nagai Yamaki; Ravi Kumar; Derek Johnson; Christopher Hunt; Mark E Jentoft; Michelle Clarke
Journal:  Rare Tumors       Date:  2017-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.